Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s344. https://doi.org/10.25251/skin.8.supp.344